← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Novatarg, Inc.
Research Triangle Park, NC
$5,464,327
Total funding
5
Grants
Funding over time
peak $2.1M · FY2013–19$2.5M$1.9M$1.3M$625K$0
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,464,327 · 5
By mechanism
R44$4,507,988 · 2
R43$956,339 · 3
Investigators at Novatarg, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel and Kidney Selective AMPK Activators to Treat Polycystic Kidney Disease$1,109,281
R44 · FY2016 · DK
Novel Biguanides to Treat Type 2 Diabetes$1,000,000
R44 · FY2018 · DK
Novel Biguanides to Treat Type 2 Diabetes$987,938
R44 · FY2016 · DK
Novel Biguanides to Treat Type 2 Diabetes$651,885
R44 · FY2015 · DK
Novel and Kidney Selective AMPK Activators to Treat Polycystic Kidney Disease$474,273
R44 · FY2015 · DK
Kidney Selective AMPK Activators to Treat Polycystic Kiney Disease$415,078
R43 · FY2013 · DK
Liver Selective AMPK Activator to Treat Type 2 Diabetes$316,261
R43 · FY2013 · DK
Novel Biguanides to Treat Type 2 Diabetes$284,611
R44 · FY2019 · DK
Novel and Selective AMPK Activator for the Treatment of Hepatocellular Carcinoma$225,000
R43 · FY2014 · CA